Publications
5808 Results
- Journal / Conference
- British Journal of Cancer 111(6):1241-1248;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25117820
- PMC
- PMC4453857
- Study Number(s)
- CTSU/E2100
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
- Journal / Conference
- Journal of the National Cancer Institute 106(3):djt456;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24563519
- PMC
- PMC3975165
- Study Number(s)
- S0000
Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention 23(8):1494-1504;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24732629
- PMC
- PMC4119495
- Study Number(s)
- S0000
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- British Journal of Haematology May;165(4):504-509;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24579885
- PMC
- PMC4209396
- Study Number(s)
- S0910
SWOG S0910: A phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention 23(8):1484-1493;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID25085836
- PMC
- PMC4120235
- Study Number(s)
- SWOG-9217
Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- American Urological Association Annual Meeting (May 16-21, 2014 Orlando, FL), abst. MP69-12; moderated poster session;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Added value of genetic risk score to the Prostate Cancer Prevention Trial (PCPT) risk calculator: findings from the PCPT study
- Journal / Conference
- Cancer Prevention Research 7(9):950-957;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24894197
- PMC
- PMC4154984
- Study Number(s)
- S0000
A functional variant in NKX3.1 associated with prostate cancer risk in the SELECT Trial
- Journal / Conference
- Journal of Urology 192(2):379-384;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID24518774
- PMC
- PMC4104140
- Study Number(s)
- SWOG-9217
Statin drug use is not associated with prostate cancer risk in men who are regularly screened
- Journal / Conference
- British Journal of Haematology 167(2):233-237;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID25039477
- PMC
- PMC4188732
- Study Number(s)
- S0919
SWOG0919: a phase 2 study of idarubucin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia
- Journal / Conference
- American Society of Preventive Oncology 2013 Annual Meeting (March 8-11, 2014, Arlington, VA), poster;
- Year
- 2014
- Research Committee(s)
- Cancer Survivorship